Cevimeline Hydrochloride 30 mg/1 (Cevimeline Hydrochloride CAPSULE) 30 mg/1

Cevimeline hydrochloride works as a selective muscarinic (M1, M3) receptor agonist. It binds to these receptors on salivary glands, stimulating them to produce more saliva. This action helps to alleviate dry mouth symptoms in patients with Sjögren’s syndrome or those who have experienced radiation-induced xerostomia.

The recommended dose of cevimeline hydrochloride is 30 mg taken three times a day. However, the prescriber sets the exact dosage based on the patient's medical condition and response to treatment. It is important to follow the prescribed dosage and consult with a healthcare provider for personalized advice.

The safety of cevimeline hydrochloride during pregnancy and breastfeeding is unknown. It is important to consult with a healthcare provider before using this medication if you are pregnant or breastfeeding. They can provide personalized advice based on your specific situation.

To order cevimeline hydrochloride from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Cevimeline hydrochloride is a muscarinic cholinergic agonist specifically indicated for treating dry mouth in patients with Sjögren’s syndrome. It works by stimulating the salivary glands to produce more saliva. Compared to other treatments, such as artificial saliva substitutes or pilocarpine, cevimeline hydrochloride may offer a different profile of efficacy and side effects. It is important to consult with a healthcare provider to determine the most appropriate treatment for your specific condition.

Cevimeline hydrochloride should be stored at room temperature away from light and moisture. It is important to keep the medication in its original packaging and out of reach of children. Follow the storage instructions provided on the packaging or by your healthcare provider to ensure the medication remains effective.

Cevimeline hydrochloride is administered orally in capsule form. It is usually taken three times a day, with or without food, as directed by your healthcare provider. It is important to follow the prescribed dosage and administration instructions to achieve the best results and minimize the risk of side effects.

While taking cevimeline hydrochloride, it is important to watch for serious or rare side effects such as extreme fatigue, irregular heartbeat, severe diarrhea, severe blurred vision, and severe nausea or vomiting. If you experience any of these symptoms, seek medical attention immediately. Always consult with your healthcare provider for personalized advice and monitoring.

Cevimeline hydrochloride should not be used by individuals with uncontrolled asthma, a known allergy to cevimeline, acute iritis, or narrow-angle (angle-closure) glaucoma. It should also be used with caution in patients with heart disease. Always consult with a healthcare provider to determine if cevimeline hydrochloride is appropriate for your specific condition.